Journal of acquired immune deficiency syndromes (1999)HumansHIV InfectionsMaleFemaleMiddle Aged
Cardiovascular Risk Assessment Using the Atherosclerotic Cardiovascular Disease Risk Score Model after Continuing or Switching to a Doravirine-Based HIV Treatment Regimen.
Priscilla Y Hsue, Georg M N Behrens, Zhi Jin Xu, Yujie Zhao, John Cmar, Rima Lahoulou, Rafael E Campo, Rebeca M Plank
Published: 202610.1097/QAI.0000000000003778
Abstract
BACKGROUND: People living with HIV (PLWH) on antiretroviral therapy have an increased risk of atherosclerotic cardiovascular disease (ASCVD). Doravirine (DOR), a non-nucleoside reverse transcriptase inhibitor, has a favorable lipid profile, minimal e…
Preview only. Read the full abstract at the source